rs363853
Variant summary
Our verdict is Pathogenic. Variant got 13 ACMG points: 13P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Moderate
The NM_000138.5(FBN1):c.529T>C(p.Cys177Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 11/18 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. C177S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000138.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 13 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBN1 | NM_000138.5 | c.529T>C | p.Cys177Arg | missense_variant | 6/66 | ENST00000316623.10 | NP_000129.3 | |
FBN1 | NM_001406716.1 | c.529T>C | p.Cys177Arg | missense_variant | 5/65 | NP_001393645.1 | ||
FBN1 | NM_001406717.1 | c.529T>C | p.Cys177Arg | missense_variant | 6/9 | NP_001393646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBN1 | ENST00000316623.10 | c.529T>C | p.Cys177Arg | missense_variant | 6/66 | 1 | NM_000138.5 | ENSP00000325527.5 | ||
FBN1 | ENST00000559133.6 | n.529T>C | non_coding_transcript_exon_variant | 6/67 | 1 | ENSP00000453958.2 | ||||
FBN1 | ENST00000537463.6 | n.529T>C | non_coding_transcript_exon_variant | 6/31 | 5 | ENSP00000440294.2 | ||||
FBN1 | ENST00000674301.2 | n.529T>C | non_coding_transcript_exon_variant | 6/68 | ENSP00000501333.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Marfan syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 04, 2012 | The p.Cys177Arg variant in FBN1 has been reported as a de novo change in 2 indiv iduals, a 4 year old individual with isolated ectopia lentis and an individual r eferred for aortopathy genetc testing (Arbustini 2005, Yang 2016). It was also i dentified in 1 individual with a clinical diagnosis of Marfan syndrome (LMM data ). In addition, two different amino acid changes have been reported at the same residue (p.Cys177Ser and p.Cys177Tyr) in two individuals with clinical features of Marfan syndrome (Attanasio 2008), suggesting that changes at this position ma y not be tolerated. This variant impacts a cysteine residue and cysteine substit utions in the calcium-binding EGF-like domains represent the majority of pathoge nic missense changes associated with Marfan syndrome. Computational prediction t ools and conservation analysis are consistent with pathogenicity. In summary, al though additional studies are required to fully establish its clinical significa nce, the p.Cys177Arg variant is likely pathogenic. ACMG/AMP Criteria applied: PM 1, PM2, PM6, PP3, PS4_Supporting. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at